PCOS Has a New Name and This is Why it Matters

If you or someone you know has been diagnosed with polycystic ovary syndrome, you may soon be hearing a different name for it.

In a landmark paper published in The Lancet on May 12, 2026, a global coalition of 56 patient and professional organizations, including the Endocrine Society, officially renamed the condition Polyendocrine Metabolic Ovarian Syndrome, or PMOS.

It is the largest renaming initiative in medical history. And the reason it happened is worth understanding.

What was wrong with “PCOS”?

The name polycystic ovary syndrome implies the defining problem is cysts on the ovaries. But researchers have confirmed that pathological ovarian cysts are not actually a feature of the condition. The name was a misnomer, and that mattered far more than it might seem.

For decades, the narrow focus on ovaries obscured what PMOS actually is: a complex, multisystem hormonal and metabolic condition with effects on weight, metabolism, mental health, skin, and the reproductive system. Because the name pointed clinicians and patients in the wrong direction, many people went undiagnosed or undertreated for years.

Globally, up to 70% of those affected remain undiagnosed. In Canada, an estimated 1.4 million women are living with the condition and fewer than half know they have it.Canadian research shows getting a diagnosis takes an average of 4.3 years, and typically requires seeing two or three healthcare providers first.

What is PMOS, exactly?

PMOS is diagnosed when a women meets at least two of three criteria: irregular or absent ovulation, elevated androgens (male hormones), or polycystic-appearing ovaries on ultrasound. But its impacts go well beyond reproduction.

Symptoms and associated conditions can include:

• Irregular or absent periods
• Excess hair growth on the face and body
• Acne and oily skin
• Weight gain or difficulty losing weight
• Difficulty conceiving
• Anxiety and depression

The metabolic risks are significant. Canadian research found that women with PCOS are 20 to 40% more likely to experience serious health outcomes over their lifetime, including hypertension, kidney disease, and eating disorders. Type 2 diabetes is three times more common in this group, often diagnosed as early as age 32.

The old name’s reproductive focus also compounded stigma, particularly in cultural contexts where fertility carries significant social weight, adding a layer of harm on top of an already under-resourced condition.

14 years in the making

The renaming process was led by Professor Helena Teede, an endocrinologist at Monash Health, alongside an international team. It was a genuinely rigorous undertaking:more than 22,000 survey responses from patients and health professionals across all world regions, multiple international workshops using modified Delphi and nominal group methods, and marketing and implementation analysis to ensure the new name could actually be adopted globally.

The agreed principles for the new name were: scientific accuracy, clarity, stigma avoidance, cultural appropriateness, and implementation feasibility. An accurate name was explicitly prioritised over simply rebranding the existing PCOS acronym.

“It was heart-breaking to see the delayed diagnosis, limited awareness and inadequate care afforded those affected by this neglected condition,” said Teede. “Make no mistake, this is a landmark moment that will lead to desperately needed worldwide advancements in clinical practice and research.”

Lorna Berry, a woman with PMOS who played a key role in the process, put it plainly: “This is about my daughters, their daughters, and the countless women yet to be born. We deserve clarity, understanding, and equitable healthcare from the very beginning.”

What happens now?

The name change comes with a three-year transition period, supported by a global education campaign, and will be fully embedded in the 2028 International Guideline update. Work is also underway to align the new name with health system coding, research classification, and disease registries.

If you have been diagnosed with PCOS, nothing about your care changes immediately. But the shift signals something important: formal recognition that this is a serious, complex, systemic condition, and that the people living with it deserve to have it understood and treated that way.

For more information and multilingual resources, visit the Monash Centre for Health Research and Implementation.

Subscribe to The Health Insider newsletter where you’ll find many more insights –  delivered straight to your inbox.

~ Read more from The Health Insider ~

• 
  PCOS Has a New Name and This is Why it Matters
  PCOS is now PMOS (Polyendocrine Metabolic Ovarian Syndrome). Discover why this landmark renaming matters for patient diagnosis and metabolic care.
• 
  Top 4 Portable Blood Pressure Monitors for Travel
  Find the best blood pressure monitor travel companion to track your heart health on the go with these 4 portable, accurate, and compact devices
• 
  Should You Take Berberine? What Health Canada and the Research Say
  Berberine is trending as “nature’s Ozempic”, but what does Health Canada actually approve it for, and is it safe to take with your medications?
• 
  How Exercise Actually Grows Your Brain
  Your muscles feed your brain! Learn how to trigger the natural chemicals that protect your memory and sharpen your daily focus.
• 
  What Is Hantavirus and Should Canadians Be Concerned?
  Hantavirus is rare but serious. Here’s what Canadians need to know about symptoms, how it spreads, and how to protect yourself.
• 
  Radon Is the Leading Cause of Lung Cancer in Non-Smokers and Most Canadians Haven’t Tested for It
  One in five Canadian homes may have elevated radon but only 12% have ever tested. Here’s what you need to know.

The information provided on TheHealthInsider.ca is for educational purposes only and does not substitute for professional medical advice. TheHealthInsider.ca advises consulting a medical professional or healthcare provider when seeking medical advice, diagnoses, or treatment. To read about our editorial review process click here.